New hope for Treatment-Resistant schizophrenia? phase 3 trial launches
NCT ID NCT07184619
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests an experimental drug called evenamide for people with schizophrenia that hasn't improved with standard antipsychotics. About 400 adults will receive either evenamide or a placebo added to their current medication for 12 weeks. The goal is to see if evenamide reduces symptoms like hallucinations and delusions better than placebo, and to check its safety.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT-RESISTANT SCHIZOPHRENIA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Ahana Hospitals LLP
RECRUITINGMadurai, Tamil Nadu, 625020, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine
SUSPENDEDBaltimore, Maryland, 21224, United States
-
Grady Behavioral Health Center, -Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine
SUSPENDEDAtlanta, Georgia, 30322, United States
-
Help Hospital
NOT_YET_RECRUITINGVijayawada, Andhra Pradesh, 520002, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Manhattan Psychiatric Center, The Nathan Kline Institute for Psychiatric Research
SUSPENDEDNew York, New York, 10035, United States
-
Masina Hospital Trust
RECRUITINGMumbai, Maharashtra, 400027, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Seth Sukhlal Karnani Memorial Hospital
NOT_YET_RECRUITINGKolkata, West Bengal, 700025, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
UCLA DGSOM, UCLA Health, UCLA Semel Institute
SUSPENDEDLos Angeles, California, 90095, United States
-
Udyan Health Care
RECRUITINGLucknow, Uttar Pradesh, 226012, India
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
University of Miami, Miller School of Medicine; Jackson Behavioral Health Hospital
SUSPENDEDMiami, Florida, 33136, United States